ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,385.45
0.18%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Noticias

NVRO

Nevro (NVRO)

Nevro Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:NVRO
FechaHoraFuenteTítuloSímboloCompañía
02/01/202515:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
17/12/202415:30PR Newswire (US)Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08NYSE:NVRONevro Corp
04/12/202415:27Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:NVRONevro Corp
18/11/202407:30PR Newswire (US)New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral ApproachesNYSE:NVRONevro Corp
14/11/202416:31Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:NVRONevro Corp
14/11/202416:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:NVRONevro Corp
14/11/202415:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
12/11/202406:00PR Newswire (US)Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion GloballyNYSE:NVRONevro Corp
11/11/202415:05PR Newswire (US)Nevro Reports Third-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
29/10/202415:30PR Newswire (US)New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation TherapyNYSE:NVRONevro Corp
10/10/202415:45PR Newswire (US)Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024NYSE:NVRONevro Corp
24/09/202407:00PR Newswire (US)Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord StimulationNYSE:NVRONevro Corp
28/08/202415:15PR Newswire (US)Nevro to Present at Wells Fargo 2024 Healthcare ConferenceNYSE:NVRONevro Corp
06/08/202415:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
06/08/202415:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
06/08/202415:05PR Newswire (US)Nevro Reports Second-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
09/07/202415:15PR Newswire (US)Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024NYSE:NVRONevro Corp
11/06/202415:15PR Newswire (US)Nevro to Present at Truist Securities MedTech ConferenceNYSE:NVRONevro Corp
17/05/202415:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
09/05/202415:05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
07/05/202415:05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
17/04/202407:30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
28/02/202415:10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
21/02/202415:06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
21/02/202415:05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
14/02/202414:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
01/02/202415:30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
29/01/202415:30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
18/01/202415:15PR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
17/01/202415:15PR Newswire (US)Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual MeetingNYSE:NVRONevro Corp
 Showing the most relevant articles for your search:NYSE:NVRO

Su Consulta Reciente

EU
AUCJL
Amundi null
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados